{"text": "TITLE:\n      Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)\nSUMMARY:\n      This prospective cohort study will provide information about: characteristics of Rivaroxaban\n      use in patients who are prescribed Rivaroxaban for the first time compared to patients who\n      are prescribed Phenprocoumon for the first time, the occurrence of intracranial haemorrhage,\n      gastrointestinal and urogenital bleeding, and the occurrence of non-infective liver disease.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  All male and female patients who have been prescribed for the first time either\n             Rivaroxaban or standard of care from the date of market authorization of rivaroxaban\n             to Dec 31, 2017\n        Exclusion Criteria:\n          -  Patients who have any record of being dispensed their index drug in the year before\n             index date (i.e. cohort entry), or who qualify for both cohorts on the same day\n", "cuis": "C1739768 C3272565 C1547582 C0947630 C1947944 C1552616 C1706244 C1739768 C0947630 C1555587 C3242430 C1561528 C0022396 C0423864 C1739768 C0278329 C0151699 C3472662 C0018946 C0238154 C0852276 C0031444 C0278329 C0023895 C2186532 C3280432 C0455417 C0019080 C2707256 C0596601 C0809794 C0017173 C0184122 C0687713 C0920703 C0017181 C0017185 C0203054 C0237938 C0436865 C0744333 C0849766 C1141929 C2697368 C0243161 C0013893 C0243161 C0278329 C2936643 C1739768 C1524004 C0243161 C0034869 C0918012 C0770655 C0013227 C1254351 C1561543 C1550655 C1578485 C1578486 C2360836 C2360838 C2360840 C0180463 C0918012 C0770655 C1561538 ", "concepts": "Rivaroxaban, Clinical, Routine, Study, Use summary, summary Rivaroxaban, study, provider, informational, Information, characteristics job, Hair characteristics Rivaroxaban, prescribed intracranial haemorrhage, Subpial intracranial haemorrhage, Subdural intracranial haemorrhage, Epidural intracranial haemorrhage, Neonatal intracranial haemorrhage, Phenprocoumon, prescribed liver diseases of, liver disease, No liver disease, FH: liver disease, bleeding, Gastrointestinal, gastrointestinal gas, gastrointestines, gastrointestinal agent, gastrointestinal tubes, gastrointestinal pains, gastrointestinal sign, gastrointestinal bleed, gastrointestinal tumor, X-ray gastrointestinal, Ulcer gastrointestinal, O/E - gastrointestinal, gastrointestinal polyp, gastrointestinal colic, edema gastrointestinal, Upset gastrointestinal criteria, Eligibility Criteria prescribed standard of care, rivaroxaban, Authorization Criteria record, index, Rindex, drug, drug, year, Patient, Patient, Patient, Patient, Patient, Patient, dispenser index, Rindex, day "}
